← Back to patent-cliff list
Metablok
Tier C — Watch / tradeMetablok
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：DPEP1
Indications (approved)：Heart disease, Acute respiratory distress syndrome, 冠状病毒感染, 急性肾损伤, COVID-19, Severe acute respiratory syndrome
Regional status
US
Phase II
2020-10-14
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Metablok?
Approved indications include: Heart disease, Acute respiratory distress syndrome, 冠状病毒感染, 急性肾损伤, COVID-19, Severe acute respiratory syndrome.
When does the Metablok patent expire?
No public expiry year is available for Metablok yet; this page updates once verified.
How do I get a quote for Metablok intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06